Encrypted login | home

Program Information

Verification of Intrafractional Positional Accuracy Using Ultrasound Autoscan Tracking for Prostate Cancer Treatment


S Yu

S Yu*, D Hristov , T Phillips , Stanford University, Stanford, CA

Presentations

SU-E-J-118 Sunday 3:00PM - 6:00PM Room: Exhibit Hall

Purpose:
Transperineal ultrasound imaging is attractive option for image-guided radiation therapy as there is no need to implant fiducials, no extra imaging dose, and real time continuous imaging is possible during treatment. The aim of this study is to verify the tracking accuracy of a commercial ultrasound system under treatment conditions with a male pelvic phantom.

Methods:
A CT and ultrasound scan were acquired for the male pelvic phantom. The phantom was then placed in a treatment mimicking position on a motion platform. The axial and lateral tracking accuracy of the ultrasound system were verified using an independent optical tracking system. The tracking accuracy was evaluated by tracking the phantom position detected by the ultrasound system, and comparing it to the optical tracking system under the conditions of beam on (15 MV), beam off, poor image quality with an acoustic shadow introduced, and different phantom motion cycles (10 and 20 second periods). Additionally, the time lag between the ultrasound-detected and actual phantom motion was investigated.

Results:
Displacement amplitudes reported by the ultrasound system and optical system were within 0.5 mm of each other for both directions and all conditions. The ultrasound tracking performance in axial direction was better than in lateral direction. Radiation did not interfere with ultrasound tracking while image quality affected tracking accuracy. The tracking accuracy was better for periodic motion with 20 second period. The time delay between the ultrasound tracking system and the phantom motion was clinically acceptable.

Conclusion:
Intrafractional prostate motion is a potential source of treatment error especially in the context of emerging SBRT regimens. It is feasible to use transperineal ultrasound daily to monitor prostate motion during treatment. Our results verify the tracking accuracy of a commercial ultrasound system to be better than 1 mm under typical external beam treatment conditions.


Contact Email: